Calago, Marlyn C.
HRN: 12-38-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/07/2024
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
07/07/2024
07/14/2024
IV
250mg
OD Every Other Day
CAP-HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes